Skip to content

Discovery: Pentax* Computer-aided Detection to Improve Adenoma Detection in a Real-time Setting - The Discovery I Study

Discovery: Pentax* Computer-aided Detection to Improve Adenoma Detection in a Real-time Setting - The Discovery I Study - The Discovery I Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50010
Enrollment
30
Registered
2020-07-14
Start date
2020-09-24
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal adenomas and polyps

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - >= 18 years; - Referred and scheduled for either diagnostic, screening (non-iFOBT based) or surveillance colonoscopy.

Exclusion criteria

Exclusion criteria: - Known colorectal tumor or polyp on referral; - Referral for a therapeutic procedure (i.e. endoscopic mucosal resection, intervention for lower gastro-intestinal bleeding, etc.); - Inadequately corrected anticoagulation disorders or anticoagulation medication use; - American Society of Anesthesiologists (ASA) score >= 3; - Known or suspected inflammatory bowel disease; - Inability to provide informed consent.

Design outcomes

Primary

MeasureTime frame
The main study parameter is the PDR, defined as the number of colonoscopies in which >=1 polyp is detected divided by the total number of colonoscopies.

Secondary

MeasureTime frame
- Mean number of polyps - Mean number of adenomas - ADR - Polyp location Caecum, ascending, transverse, descending, sigmoid, rectum - Polyp shape according to the Paris classification Ip, Is, IIa, IIb, IIc, III - Polyp size 0-5 mm, 6-10 mm, 10-20 mm, >20 mm - Polyp type Adenoma, sessile serrated lesion, hyperplastic polyp - Withdrawal time (minutes) - Procedure time (minutes) - Boston Bowel Preparation Scale (3-9) - (Serious) Adverse events - Endoscopists* evaluation of: Number of polyps that would have been missed without the CADe-system; - Endoscopists* subjective evaluation on a Likert scale of: User friendliness

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)